RLAY (NASDAQ: RLAY) Form 144: 50,000 Performance Stock Units; 753-share sale

Rhea-AI Filing Summary

RLAY Section 144 notice reports intent related to 50,000 Performance Stock Units dated 01/29/2025 and discloses a recent sale of 753 Common shares on 04/28/2026 for $11,136.87. The filing lists Morgan Stanley Smith Barney LLC as the broker and includes a table row dated 06/30/2026.

Insights

Securities Compliance Analyst

Routine Section 144 filing showing a brokered resale notice and a small recent sale.

The filing lists 50,000 Performance Stock Units with an effective date of 01/29/2025 and names Morgan Stanley Smith Barney LLC as the brokerage intermediary. It also records a completed sale of 753 Common shares on 04/28/2026 for $11,136.87.

These disclosures are administrative: they inform market participants of intended/resale activity and an executed small transaction. Subsequent filings would show actual resale volumes or settlement details.

Key Figures

Performance Stock Units listed: 50,000 shares Completed sale: 753 shares Proceeds from sale: $11,136.87 +3 more

6 metrics

Performance Stock Units listed 50,000 shares Securities to be sold, date 01/29/2025

Completed sale 753 shares Sale date 04/28/2026

Proceeds from sale $11,136.87 Sale on 04/28/2026

Broker listed Morgan Stanley Smith Barney LLC Securities information table

Table date 06/30/2026 Securities information row

Table number 191,586,165 Value appearing in securities information row dated 06/30/2026

Key Terms

Performance Stock Units, Form 144, Securities To Be Sold

3 terms

Performance Stock Units financial

"Performance Stock Units are listed in the securities-to-be-sold row"

Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.

Form 144 regulatory

"Header indicates form type 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Securities To Be Sold regulatory

"The excerpt includes a 'Securities To Be Sold' table row"

FAQ

What did the RLAY Form 144 disclose about Performance Stock Units?

The filing lists 50,000 Performance Stock Units dated 01/29/2025. It identifies these units in the securities-to-be-sold section without additional pricing or proceeds detail.

How many RLAY shares were sold recently under this filing?

The filing reports a sale of 753 Common shares on 04/28/2026, with reported proceeds of $11,136.87 attributable to that transaction.

Which broker is named on the RLAY Form 144?

The document names Morgan Stanley Smith Barney LLC (Executive Financial Services, 1 New York Plaza) as the broker listed in the securities table.

Does the filing state the shares outstanding for RLAY?

The table includes the number 191,586,165 adjacent to other rows with date 06/30/2026, which appears in the securities information section of the excerpt.

Is the reported sale large enough to indicate a material insider disposition?

The filing documents a sale of 753 shares for $11,136.87. The excerpt provides no analysis of materiality or percent ownership implications.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/30/2026 - 04:35 PM Accepted by SEC EDGAR 06/30/2026 - 04:35 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001959229
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RELAY THERAPEUTICS INC
SEC File Number	001-39385
Address of Issuer	60 Hampshire Street Cambridge MASSACHUSETTS 02139
Phone	617-370-8837
Name of Person for Whose Account the Securities are To Be Sold	PETER RAHMER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	987000.00	191586165	06/30/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/29/2025	Performance Stock Units	Issuer			50000	01/29/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
PETER RAHMER 60 Hampshire Street Cambridge MA 02139	Common	04/28/2026	753	11136.87

144: Remarks and Signature

Remarks
Date of Notice	06/30/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	10/31/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Peter Rahmer
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)